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Objective. To appraise and synthesise studies evaluating the clinical and cost effectiveness 
of conservative interventions for chronic lower extremity musculoskeletal (MSK) 
conditions and describe their characteristics, including type of economic evaluation, 
primary outcomes and which conditions. 
Methods. The search strategy related to economic evaluations of lower limb MSK 
conditions that utilised conservative therapies. Eight electronic databases were searched 
(CENTRAL, MEDLINE, PubMed, EMBASE, CINAHL, PEDro, NHSEED, and Proquest) and 
reference lists from included articles. Quality of articles was appraised using a modified 
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version of the economic evaluations’ reporting checklist (economic) and The Cochrane 
Collaboration’s tool for assessing risk of bias (clinical). 
Results. Twenty six studies were eligible and included in the review. Economic evaluations 
of conservative interventions for osteoarthritis or pain affecting the knee/hip (N=25; 93%) 
were most common. The main approaches adopted were cost utility analysis (N=17; 68%) 
or cost effectiveness analysis (N=5; 19%). Two studies involved interventions including 
footwear/foot orthoses; for heel pain (N=1; 4%) and overuse injuries (N=1; 4%). 50% of 
economic evaluations adopted the EQ-5D-3L as the primary outcome measure for quality 
of life and QALY calculations.  
Conclusions. Economic evaluations have been conducted largely for exercise based 
interventions for MSK conditions of the hip and knee. Few economic evaluations have 
been conducted for other clinically important lower limb MSK conditions. A matrix 
presentation of costs mapped with outcomes indicated increasing costs with either no 
difference or improvements in clinical effectiveness. The majority of economic evaluations 
were of good reporting quality, as were the accompanying clinical studies. 
 
Key words:  systematic review, economic evaluation, lower extremity musculoskeletal 
conditions, cost effectiveness, conservative interventions 
 
Key messages 
• Comprehensive systematic review of economic evaluations of conservative 
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• Economic evaluations of hip and knee osteoarthritis dominate cost-
effectiveness literature for lower extremity musculoskeletal conditions. 
• Reporting quality of clinical and economic evidence for lower extremity 
musculoskeletal conditions is generally good. 
 
INTRODUCTION 
Worldwide over 20% of the population have a musculoskeletal (MSK) condition (1). These 
conditions are one of the main drivers of increasing years lived with disability (YLD) (2, 3) 
and their management has major implications for health care resource use. A wide range 
of inflammatory and degenerative conditions are classed as MSK conditions (4) and they 
are often characterised by pain, limitations on physical function and reductions in health-
related quality of life (5). For many MSK conditions the first line of management is 
conservative treatment. This may include options such as exercise programmes, self-
management education, and physical therapies (6). However, evidence of clinical and cost 
effectiveness for conservative interventions for MSK conditions remains equivocal.  While 
there is a growing evidence base for clinical effectiveness for some conservative 
treatments, the evidence for cost effectiveness is often lacking.  This is problematic given 
that health care systems must deal with resource allocation constraints.  To maximise 
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 The overall aim of economic evaluations in health care is to aid decision makers to make 
efficient and equitable decisions (7). Economic evaluation involves the comparison of two 
or more health care interventions, typically comparing a new intervention with usual care, 
in terms of the costs and the consequences (7, 8)  The inclusion of the outcomes as well as 
costs is crucial if we are to determine which interventions produce the greatest health 
gain for our given budget. (For a glossary of economic terms, see (9)) 
 Systematic reviews are useful to assess evidence of effects, adverse effects and health-
related quality of life (HRQOL) as well as to identify gaps in research (10). Systematic 
reviews of economic evaluations can be used to establish the current state-of-the-art in 
economic evaluations of interventions that assess cost effectiveness and provide a 
foundation for higher methodological standards (8, 11). While previous reviews of cost-
effectiveness of non-pharmacologic and non-surgical treatments for MSK conditions have 
focused on specific patients or interventions (12, 13), the current study sought to increase 
scope to include any attempt to compare costs with benefits for any lower extremity MSK 
condition.  
Accordingly, the aim of this review was to: identify and critically appraise the current 
evidence of clinical and cost effectiveness of conservative interventions for the treatment 
of lower extremity MSK conditions to determine whether there is sufficient evidence to 
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economic evaluations including type of economic evaluation, primary outcomes, which 




The protocol for the systematic review was submitted and approved a priori (PROSPERO 
2015:CRD42015024441 (15)) and followed the Preferred Reporting Items for Systematic 
Reviews and Meta-Analyses (PRISMA) guidelines (16).  
 
Search strategy 
Peer-reviewed literature was searched using a predefined strategy using a combination of 
medical subject headings (MeSH) related to MSK and physical body location and keywords 
(any field), including text words related to economic evaluation (supplementary table S1, 
available at Rheumatology Advances in Practice online).  The strategy was wide in scope in 
order to be inclusive so that relevant studies were returned.    
The search was conducted for studies published up to10 September 2017. Eight databases 
were searched:  Cochrane Central Register of Controlled Trials (CENTRAL), Medical 
Literature Analysis and Retrieval System Online (MEDLINE), PubMed, Excerpta Medica 
database (EMBASE), Cumulative Index to Nursing and Allied Health Literature (CINAHL), 
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EED)(addition of bibliographic records to NHS EED ceased after 31 March 2015), and 
Proquest.  Results were imported to Endnote (Endnote; Version 7.1, Thomson Reuters). 
 
Inclusion Criteria 
Articles reporting an economic evaluation of health professional delivered conservative 
intervention for the treatment of MSK conditions of the lower extremities were the focus 
of the systematic review (Table 1). Medical treatments such as pharmacological, 
homeopathic and surgical interventions were excluded. Studies that were primarily clinical 
but had some analysis of cost in relation to benefit (using an economic tool or method to 
calculate outcome) were included prior to a process of screening to ascertain whether 
they met economic evaluation definitions (UK classification system (7)).  Articles reporting 
embedded economic evaluations, including randomised controlled trials or quasi-
randomised controlled trails, controlled trials, pilot studies were eligible for inclusion. 
Adult lower extremity MSK conditions considered theoretically to have a mechanical 
aetiology (such as osteoarthritis (OA), stress trauma, overuse injuries, or biomechanical 
misalignment) were included.    In addition, only conditions affecting the lower limb 
(International Classification of Functioning, Disability and Health (17) structures of the 
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Pharmacological, and homeopathic, or surgical interventions were excluded. Systemic 
conditions, such as diabetes or rheumatoid arthritis, as well as neurological conditions 
whereby the primary condition was not MSK in origin, were excluded.  Lower extremity 
MSK conditions resulting from acute or injury trauma (e.g., athletic ankle sprain, 
professional ballet injuries) were excluded. MSK complaints in axial regions, torso and 
upper extremity were excluded.  Non-peer reviewed documentation, such as 
commentaries, letter, editorials, were excluded. Articles were limited to those available in 
English.  No restrictions were placed on publication date. 
 
Study selection 
Studies were identified, selected and appraised using methodology in line with The 
Cochrane Handbook for Systematic Reviews (10). Title screening of studies was 
undertaken by one reviewer [LF], using the keywords and MeSH terms to determine if the 
title warranted further consideration for review.  This was followed by independent 
review of abstracts, then full text, by two authors [LF + GH].  At each stage, reviewer 
agreement or disagreement was recorded with justification.  For included articles, if the 
economic evaluation referred to a primary clinical paper then a copy of that was sought 
and included in the review.  Economic and accompanying clinical articles were treated as 
one study.   Reference lists of included studies were hand searched. 
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The data extraction tool for this review included patient population, study design, 
economic evaluation method, intervention, follow-up, and clinical and cost effectiveness 
outcomes. This data extraction tool was used independently by two authors [LF and GH].  
 
Quality assessment 
Reporting quality of economic evaluations of the included studies was independently 
assessed by two authors [LF and GH] using a modified version of the economic 
evaluations’ reporting checklist (18, 19). The modified checklist included 13 items (plus an 
additional 2 items applicable for decision analytic modelling studies). The included items 
were selected based on their direct relevance to economic evaluations of single clinical 
treatment studies and the specific research question for the systematic review. Clinical 
studies were evaluated for their quality separately using The Cochrane Collaboration’s 
tool for assessing risk of bias (10, 20) .  
 
Synthesis of evidence 
Evidence of cost-effectiveness relative to clinical effectiveness was summarised using a 
matrix (8).  The matrix was developed to aid discussion about the choices between health 
care interventions that are available to managers and clinicians. It provides a visual 
representation and summary of available clinical and economic evidence. By mapping 
these two sources of evidence together it demonstrates both technical efficiency (which 
interventions are offering most clinical benefit for the resources used) and opportunity 











niversity user on 12 Septem
ber 2018
Statements of clinical effectiveness and evidence of cost-effectiveness was accepted as 
reported by study authors. This was a pragmatic decision based on the fact all included 
studies had been peer reviewed.  Clinical effectiveness relative to the treatment 
comparator is mapped horizontally. Evidence of impact on resources in terms of marginal 
change is mapped vertically. The main feature of utility of the matrix is that it provides 
easily accessible information to aid decision-making by healthcare providers concerning 
treatment options.  
It is recommended that only studies appraised as good quality are mapped in the matrix 
(8).  Studies were included in the matrix if they had a quality score between 70% to 100% 
for both clinical reporting (10, 20) and economic reporting (18, 19). Reported conclusions 
about clinical and cost effectiveness were mapped to one another. For studies that 
involved more than one intervention-comparator pairing, these were mapped by each 
individual intervention to the comparator (thirteen studies, 21 pairs). Studies with 
insufficient information about intervention-comparator pairings could not be mapped 




A total of 24,754 records were returned as a result of searching, and after removing 
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criteria, the review of titles excluded 17,274 records, leaving 1,578. At the abstract stage, 
1,492 were excluded, leaving 86 records for full text review.  27 articles met the inclusion 
criteria including one additional article identified through reference lists.  Of these, two 
economic papers (21, 22) reported on the same analysis of the same study, meaning in 
total there were 27 articles representing 26 unique studies. 
 
Studies included in review 
Data extracted from 26 included studies were from the economic articles (21-47) and their 
associated clinical papers (48-64) (Table 2).  The majority of studies were written as 
separate economic evaluations (N=15; 58%) with an associated clinical paper, while a 
minority included embedded reporting of economic evaluation (N=11; 42%) in the parent 
article. Using the UK definition of economic evaluation approaches (7), there were: 17 cost 
utility analyses (CUA), five cost effectiveness analyses (CEA), three cost consequence 
analyses (CCA), and one cost minimisation analysis (CMA). Articles were published 
between 1999 and 2017.  
 
Conservative interventions 
The conservative interventions of the included economic evaluations were of exercise-
based intervention (N=11; 42%), education (N=3; 12%), combined exercise and education 
(N=3; 12%), combined exercise and diet (N=2; 8%), acupuncture (N=3; 12%), 
footwear/orthoses (N=2; 8%), physical therapy (N=1; 4%) and mud-bath therapy (N=1; 
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OA or pain management affecting the knee/hip (N=24; 92%). The remaining studies 
evaluated conservative interventions for heel pain (N=1; 4%) and lower limb overuse 
injuries (N=1; 4%).   
 
Primary outcome measures 
Of the included studies, the most commonly used outcomes measures adopted for 
evaluating the clinical and cost-effectiveness of conservative treatments were the 
Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) (cost-
effectiveness analysis) and the generic preference based measure EQ-5D-3L, developed by 
the EuroQoL group (cost-utility analysis). Two studies were concerned with foot and ankle 
conditions, using the Foot Health Status Questionnaire (FHSQ) (38) and an investigator-
developed questionnaire (43) respectively.   
Five generic preference based outcome measures were used by 21 economic evaluations: 
EQ-5D-3L (12 CUAs, 1 CEA and 1 CCA), SF-36 (2 CUAs, 1 CEA [RAND-36], 1 CMA), SF-12v2 
(1 [SF-6D]) CUA), AQoL-6D (1 CUA), and HUI-3 (1 CUA). Each of these tools produce utility 
values that can be used in the calculation of QALYs (quality adjusted life years), essential 
for comparisons across different diseases. Three studies collected only clinical measures of 
health for hip OA and knee OA and so were restricted to CEA methodology (i.e. cost per 
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an investigator-developed questionnaire to undertake a CEA (39). Two studies collected 
utilisation of health care and cost data and conducted a CCA (34, 43).  
 
Quality of the evidence 
The reporting quality of economic evaluations and related clinical studies was generally 
good (for this review, defined as scoring between 70% to 100% for items on each 
reporting quality checklist) (Table 3). Ten studies reported on all 13 of the economic 
evaluations’ reporting list items that were selected for appraisal (21, 22, 24, 27, 28, 31, 33, 
35, 36, 41, 44). A further nine studies reported on more than 70% of the items (23, 25, 26, 
32, 37, 42, 46, 47, 65) and four studies were considered to have reported on at least half 
of the key elements (29, 34, 39, 43).  The remaining three were appraised to have poor 
reporting quality (30, 40, 45).  Witt et al (45) did not report adequately on resource use 
and methods for estimation of quantities and unit costs.  Juhakoski et al (30) reporting of 
methods for estimation and quantities of costs was restricted because they were using 
study data collected for clinical effectiveness considerations, not economic.  Stan et al (40) 
was judged to have poor reporting quality for both clinical and economic considerations. 
Sampling strategy was not reported, nor why EQ-5D-3L administration was at different 
follow-up intervals for different intervention arms.  
Sixteen clinical studies were appraised as good quality with low risk of bias (21, 24, 25, 27, 
30, 43, 46, 48, 49, 51-53, 55, 59-61), five appraised as medium risk of bias (29, 38, 41, 57, 
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common to most of the studies.  As would be expected with interventions involving such 
treatment as exercise or footwear, it was not possible to blind participants and assessors. 
Higher risk of bias due to incomplete outcome data was also noted in more than half of 
the studies (21-23, 25, 29-31, 33, 37, 39, 40, 42, 44, 45, 50-52, 54, 60, 65) although this is 
not unusual for interventions that require adherence, such as exercise therapies.  It should 
be noted that Tan (41) reported that a clinical article is forthcoming, and so the judgement 
about risk of bias, made on the basis of the available evidence in the economic evaluation 
article.  
 
Cost effectiveness of interventions 
Economic evidence, for studies with a quality score between 70% to 100% for both clinical 
reporting (10, 20) and economic reporting (18, 19) (Table 4), was synthesised in a matrix 
(Table 5). The reported evidence for exercise interventions for hip/knee OA is mixed, with 
studies reporting in A1 (evidence of greater clinical effectiveness and reductions in costs) 
(25, 28, 42, 46), B1 (evidence of greater clinical effectiveness with no difference in costs) 
(24, 28) and B2 (evidence of no difference in clinical effectiveness and no difference in 
costs reported, relative to comparator) (21, 22, 26, 44), C1 (evidence of greater clinical 
effectiveness and greater costs) (36, 44) and C2 (evidence of no difference in clinical 
effectiveness and greater costs) (28, 35, 66) and C3 (evidence of less effectiveness and 
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effectiveness with greater cost, when compared to exercise and advice. However, the 
same study sought to compare true and non-penetrating acupuncture and found no 
difference in clinical effectiveness and no difference in costs (mapping in B2).  Mud-based 
therapy for pain management in knee OA (46) mapped in A1, reflecting the research 
findings that clinical effectiveness of standardised care was enhanced by the addition of 
MBT to standardised care. 
 
DISCUSSION  
The findings of this review provide an overview of the characteristics and reporting quality 
of economic evaluation of conservative interventions for common lower extremity MSK 
conditions. Twenty-six unique studies which assessed clinical effectiveness and cost 
effectiveness of conservative, non-pharmacological and non-surgical rehabilitative 
interventions for lower limb musculoskeletal conditions were identified and appraised. 
Despite a deliberately broad scope search strategy, it is of note that the overwhelming 
majority evaluated treatments for hip OA and knee OA involving an exercise component, 
with only 2 focused on common disorders of the foot and ankle, and 1 on chronic pain 
(with OA of the hip or knee included in the range of conditions).  This is unsurprising given 
the prevalence of hip/knee OA problems in populations (67) and the medical priority to 
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Reporting quality for economic evaluation was generally in accordance with clinical 
reporting quality recommendations, whether published as a separate economic 
evaluation article or within the clinical article, with a few exceptions.  Of those that were 
judged to be less well reported for economic evaluation than for clinical effectiveness, this 
may have been a consequence of the scale of the research programme and study 
objectives. Pilot and feasibility studies are typically conducted with smaller samples, and 
objectives are inherently different to that of definitive RCTs. Others faced restrictions on 
the type and scope of economic analysis that can be conducted when data has not been 
explicitly collected for economic evaluation as part of the original study design. This was 
the case for Juhakoski et al (30) who conducted a post-hoc economic evaluation using 
information collected during the clinical study.  In addition, consideration should be given 
to whether weaker reporting quality may also partly be a consequence of translation (for 
example, when an article has a dual language abstract (40)).  
To make decisions about resources it is useful to present information on costs and 
outcomes for each of individual intervention arm with the comparator.  For example, 
Barton et al (23) involved multiple trial intervention arms: usual care provision compared 
to dietary intervention, to strengthening exercises, and to a combination of diet and 
exercise. The use of a comparator that is equivalent to standard (or usual) care provides a 
pragmatic result that can be used for making policy decisions about resource allocation.  
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usual care, the external validity of both the RCT and the economic evaluation become 
limited.  
The outcome measures adopted by included studies were largely appropriate for the 
evaluations of interventions’ clinical and cost-effectiveness.  Provided that sufficient 
validation and evaluation of measurement properties have been undertaken patient 
reported outcome measures provide a means by which to assess and quantify the health 
consequences of health care for patients with specific conditions. In contrast economic 
evaluation requires comparability across different disease conditions via use of a common 
metric.  QALYs provide a common metric and can be calculated using preference-based 
single index measure for health.  These can be collected using generic preference based 
measures such as EQ-5D (used by the majority of included studies) and also by conversion 
to SF-6D from SF-36 and SF-12. However, the measurement properties of the generic 
preference based measure (i.e. EQ-5D) for specific conditions should be known/evaluated 
prior to use in that specific clinical context. The lack of specificity of generic preference 
based measures has been highlighted as a concern (68). Given the potentially small and 
subtle changes that occur following conservative interventions for MSK conditions, 
accurate estimation of improvements is important to estimate both the burden and the 
consequent impact of health care treatments.  The possibility of ceiling effects limiting 
sensitivity to small changes in health has led to the development of a new 5 level version 
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musculoskeletal population in future due to the ability to better discriminate between full 
health states, particularly for domains such as mobility (69). Research to understand the 
full implication of using EQ-5D-5L and its value sets for QALY calculations is supported by 
NICE (70).  
The paucity of evidence about cost effectiveness of conservative, non-pharmacological 
and non-surgical rehabilitative interventions for the range of lower limb MSK conditions is 
a concern.  Consistent pressures on demand for health care worldwide, coupled with a 
changing landscape due to demographic and health care developments, make the need 
for clinical and cost effectiveness evidence more pertinent.  Including economic evaluation 
in clinical trial design will build the evidence base about clinical and cost effectiveness.  
Presenting the evidence in a form such as the matrix used for this review aids decision 
makers to consider clinical and economic evidence together. The ideal intervention would 
be in A1 where it would be both more effective and use less resources, but C1 is typically 
where new treatments map.  Often a new intervention offers improvements in outcomes 
but generally will also cost more (i.e. increased resource use).  The studies included in this 
review mainly fall into C1 and C2. Presentation of clinical and cost effectiveness 
information in a matrix is intended to facilitate discussions about ways to achieve 
maximum health gain through resource allocation decisions.  C1 indicates greater costs 
with greater effectiveness. To make use of this, decision makers should also consider 
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specific cost-effectiveness thresholds (explicit or implicit).  C2 costs more and does not 
deliver outcomes any better than the comparator (in the trial), so it would be advisable 
not to introduce this intervention. 
The systematic review sought to be broad in scope to encompass any type of economic 
evaluation of any conservative intervention for any lower extremity MSK condition of 
mechanical aetiology.  To focus on a specific disease and a specific physical location using 
a PICO type strategy would have narrowed the returned titles but at the cost of restricting 
confidence that all relevant studies had been identified.  There are limitations to this 
systematic review that are worth highlighting.  Restricting studies to conservative 
treatments excluded co-provision of treatments (for example, exercise therapy with 
pharmacological treatment). This was purposeful in order to determine the reported 
clinical effectiveness of conservative treatment.  It may be that co-provision of treatment 
would be more aligned to real world health care practice and should be considered.  The 
desire to consider clinical effectiveness meant excluding economic evaluations of 
interventions undertaken in general populations.  Research of this nature is often focused 
on preventative measures and the economic interest is prediction of prevented demand 
and avoided costs, rather than management of existing health care budgets given current 
demand for health care.  
The dominance of exercise based interventions for MSK conditions of the hip and knee, 
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such as foot and ankle disorders, highlights a gap in the literature and therefore current 
knowledge. Common MSK conditions of the lower leg, such as Achilles tendinopathy or 
plantar fasciitis, are prevalent (71-73) and have resource implications for health care 
systems.  It would appear that the body of clinical evidence for conservative interventions 
for conditions such as these (74, 75) is not currently complemented by economic 
evidence, although the reasons for this are unclear.  
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Figure 1: PRISMA diagram for Systematic review 
 
Table 1: Systematic review study criteria 
Criteria Description 
Study design Included studies were economic evaluation articles with their 
associated clinical article or studies reporting embedded 
economic evaluations, of conservative, non-pharmacological and 
non-surgical interventions for lower extremity musculoskeletal 
conditions. 
Excluded studies reported surgical or pharmacological 
interventions for upper extremity musculoskeletal conditions. 
Study participants Adult humans (as defined by study). 
Included: Lower extremity (hip, thigh, knee, calf, ankle, foot and 
toes(s)) musculoskeletal conditions that originate in, and having a 
mechanical aetiology, affect the musculoskeletal system. 
Excluded: systemic conditions (such as cancer, vascular, multiple 
sclerosis, gout, diabetes, for example) 
Study time frame No restrictions 
Outcomes measures Studies were assessed for: 
Scope and range of evidence of clinical effectiveness and cost 
effectiveness. 
Quality of the evidence. 
Identification of common outcome measures used, clinical and/or 
economic. 
Analysis Descriptive synthesis, summary of findings table, decision matrix 
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intervention (number of 
participants) 









outcome tool - 








Barton, G. R., et 
al. (2009) (19)  
[clinical (50)] 
knee pain CUA dietary intervention plus 
strengthening exercises 
(n=109) 
leaflet provision (equivalent 
to standard care) (n=76) 
WOMAC  EQ-5D-3L  
    dietary intervention 
(n=122) 
leaflet provision (equivalent 
to standard care) (n=76) 
WOMAC  EQ-5D-3L  
      strengthening exercises 
(n=82) 
leaflet provision (equivalent 
to standard care) (n=76) 
WOMAC  EQ-5D-3L  
Bennell, K.L. et 
al (2016) (20) 
[clinical not yet 
available] 
knee OA CUA PCST and exercise (n=73) exercise (n=75) VAS knee pain 
plus WOMAC 
 AQoL-6D  
    PCST and exercise (n=73) PCST (n=74) VAS knee pain 
plus WOMAC 
 AQoL-6D  
      PCST (n=74) exercise (=75) VAS knee pain 
plus WOMAC 
 AQoL-6D  
Ciani, O., et al. 
(2017) (42) 
[clinical (60)] 
knee OA CUA Mud-bath therapy 
(n=53) 
usual care (n=50) WOMAC  EQ-5D-3L  
Cochrane, T., et 
al. (2005) (21) 
hip OA + 
knee OA 
CUA water-based exercise 
(n=153) 
usual care (n=159) WOMAC  SF36, EQ-5D-3L   
Coupé, V. M. H., 
et al. (2007) (22) 
[clinical (57)] 
hip OA + 
knee OA 
CUA Behavioural graded 
activity (n=56) 
usual care (n=66) VAS knee pain 
plus WOMAC 
 EQ-5D-3L  
Hurley, M. V., et 
al. (2007) (24) 
[clinical (49)] 
knee pain CUA exercise-based 
rehabilitation program 
(n=278) 
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    individual exercise-based 
rehabilitation program 
(n=146) 
usual care (n=140) WOMAC  EQ-5D-3L  
    group exercise-based 
rehabilitation program 
(n=132) 
usual care (n=140) WOMAC  EQ-5D-3L  






WOMAC  EQ-5D-3L  
Hurley, M. V., et 
al. (2012) (23) 
knee pain CUA exercise-based 
rehabilitation program 
(n=189) 
usual care (n=94) WOMAC  as clinical -- 
Jessep, S. A., et 
al. (2009) (25) 





WOMAC  EQ-5D-3L  
Juhakoski, R., et 
al. (2011) (26) 
hip OA CCA combined exercise and 
usual care (n=60) 
usual care (n=58) WOMAC  RAND-36 (SF-
36) 
 
Lord, J., et al. 
(1999) (27) 
[clinical (46)] 
knee OA CMA Nurse-led education 
(n=105) 
usual care (n=65) WOMAC  SF-36  
Losina, E., et al. 
(2015) (28)  
[clinical (51, 52)] 
knee OA CUA arthroscopic partial 
meniscectomy (n=351) 
physical therapy (n=164) WOMAC  EQ-5D-3L -- 
Marra, C. A., et 
al. (2014) (29) 
[clinical  
knee OA CUA Pharmacist led health 
care (n=66) 







 HUI3  
Mazzuca, S. A., 
et al. (1999) (30) 
[clinical (54)] 
knee OA CCA education (individualized 
arthritis self-care 
instruction) (n=105) 
attention control (n=106) HAQ  n/a (health 
care utilisation 
and costs data) 
-- 
McCarthy, C. J., 
et al. (2004) (17) 
knee OA CUA class-based exercise 
programme + home 



















Patel, A., et al. 
(2009) (31) 
[clinical (45)] 
hip OA + 
knee OA 
CUA Arthritis self 
management 
programme plus an 
education booklet 
(n=406) 
education booklet (reflects 
standard care) (n=406) 
SF-36  EQ-5D-3L  
Pinto, D., et al. 
(2013) (32) 
[clinical (44)] 
hip OA + 
knee OA 
CUA manual therapy (n=54) usual care (n=51) WOMAC  SF12v2 (SF-6D)  
    exercise therapy (n=51) usual care (n=51) WOMAC  SF12v2 (SF-6D)  
      manual and exercise 
therapy (n=50) 
usual care (n=51) WOMAC  SF12v2 (SF-6D)  
Reinhold, T., et 
al. (2008) (33) 
[clinical (58)] 
OA CUA acupuncture (n=246) delayed acupuncture 
(equivalent to no treatment) 
(n=243) 
WOMAC  SF-36 (SF-6D)  
Richardson, G., 
et al. (2006) (18) 
knee OA -- -- -- -- -- -- -- 
Rome, K., et al. 
(2004) (61) 
heel pain CUA accomodative orthoses 
(n=22) 
functional orthoses (n=26) FHSQ  EQ-5D-3L  
Sevick, M. A., et 
al. (2000) (35) 
[clinical (47)] 
knee OA CEA aerobic exercise (n=144) education booklet (reflects 








    resistance exercise 
(n=146) 
education booklet (reflects 








    resistance exercise 
(n=146) 







Sevick, M. A., et 
al. (2009) (43) 
[clinical (55)] 
knee OA CEA diet (n=82) healthy lifestyle control 
(attention control 
comparison) (n=78) 
WOMAC  as clinical -- 
    exercise (n=80) healthy lifestyle control 
(attention control 
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comparison) (n=78) 
    diet + exercise (n=76) healthy lifestyle control 
(attention control 
comparison) (n=78) 
WOMAC  as clinical -- 
    diet + exercise (n=76) diet (n=82) WOMAC  as clinical -- 
    diet + exercise (n=76) exercise (n=80) WOMAC  as clinical -- 
      exercise (n=80) diet (n=82) WOMAC  as clinical -- 
Stan, G., et al. 
(2015) (36) 
knee OA CUA unilateral TKA (non-
operated knee) (n=30) 
rehabilitation care (n=30) EQ-5D-3L  as clinical -- 
    TKA following HTO 
(n=30) 
rehabilitation care (n=30) EQ-5D-3L  as clinical -- 
      unilateral TKA (non-
operated knee) (n=30) 
TKA following HTO (n=30) EQ-5D-3L  as clinical -- 
Tan, S.S. et al 
(2016) (37) 
hip OA CUA exercise therapy added 
to GP care (n=101) 




Thomas, K. S., et 
al. (2005) (38) 
[clinical (56)] 
knee pain CEA exercise + telephone 
support + placebo 
(n=114) 
exercise + telephone support 
(n=121) 
WOMAC  as clinical -- 
    placebo (n=78) no intervention (=78) WOMAC  as clinical -- 
    exercise therapy (n=235) Combined no intervention 
and placebo (n=156) 
WOMAC  as clinical -- 
    monthly telephone 
support (n=160) 
Combined no intervention 
and placebo (n=156) 
WOMAC  as clinical -- 
      exercise + telephone 
support (combining 
exercise + telephone 
support with exercise + 
telephone support + 
placebo) (n=235) 
Combined no intervention 
and placebo (n=156) 
WOMAC  as clinical -- 




CCA new, individually 
adjusted footwear with 
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G. T., et al. 
(2011) (40) 
[clinical (48)] 
knee OA CUA advice and exercise plus 
true acupuncture 
(n=117) 
advice and exercise (n=116) WOMAC  EQ-5D-3L  
      advice and exercise plus 
true acupuncture 
(n=117) 
advice and exercise plus non-
penetrating acupuncture 
(n=119) 
WOMAC  EQ-5D-3L  
Witt, C. M., et 
al. (2006) (41) 




CUA acupuncture (n=322) usual care (n=210) WOMAC  SF-36  
statistically significant change, not a statistically significant change. Statistical significance based on author’s definition. AQoL-6D: Assessment of Quality of 
Life – 6D scale; EQ5D: EuroQol 5 dimensions; EQ-VAS: EuroQol visual analogue scale; FHSQ: Foot Health Status Questionnaire; HOOS: Hip disability and 
Osteoarthritis Outcome Score; HUI3: Health Utilities Index Mark 3; SF-6D: Short form 6 Dimensions; SF-12: Short form 12; RAND-36: Finnish-validated SF-36-
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Table 3: Summary of interventions by lower extremity (26 included studies) 
Anatomical location of MSK condition 
Intervention 






knee hip knee foot total 
acupuncture 
  (deep needling, superficial 
needling, true acupuncture, non-
penetrating) 2 1 3 
education 
  (education booklet, self-care 
education, nurse-led education 
programme) 1 2 3 
exercise 
  (aerobic exercise, resistance 
exercise, exercise aimed at 
increasing lower limb strength, and 
endurance, and improving balance) 2 2 7 11 
exercise + diet 
  (health eating diet plus quadriceps 
strengthening exercises) 2 2 
exercise + education 
  (behavioural graded activity 
integrating the concepts of operant 
conditioning with exercise therapy, 
supervised exercise and pain 
management and coping strategies) 1 2 3 
footwear 
  (functional orthoses, 
accommodative orthoses, sports 
shoe) 1 1 2 
mud-bath therapy 
  (mud-packs and hot mineral baths 
in addition to usual treatment) 1 1 
physical therapy 
  (manual physiotherapy) 1 1 
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Table 4: Quality of economic evaluation and clinical reporting in the studies included in 
the review 
  Quality score 






Barton, G. R., et al. (2009) 85%a   14%c 
Bennell, K. L., et al. (2016) 100%a 86%a   
Ciani, O., et al. (2017) 92%a   71%a 
Cochrane, T., et al. (2005) 83%a 71%a   
Coupé, V. M. H., et al. (2007) 92%a   86%a 
Hurley, M. V., et al. (2007) 100%a   86%a 
Hurley, M. V., et al. (2012) 100%a 86%a   
Jessep, S. A., et al. (2009) 55%b 57%b   
Juhakoski, R., et al. (2011) 46%c 71%a   
Lord, J., et al. (1999) 100%a   14%c 
Losina, E., et al. (2015) 87%a   71%a 
Marra, C. A., et al. (2014) 100%a   57%b 
Mazzuca, S. A., et al. (1999) 67%b   57%b 
McCarthy, C. J., et al. (2004) 100%a 71%a   
Patel, A., et al. (2009) 100%a   86%a 
Pinto, D., et al. (2013) 100%a   86%a 
Reinhold, T., et al. (2008) 77%a 43%c   
Richardson, G., et al. (2006)d -- --   
Rome, K., et al. (2004) 83%a 57%b   
Sevick, M. A., et al. (2000) 67%b   71%a 
Sevick, M. A., et al. (2009) 85%a   86%a 
Stan, G., et al. (2015) 31%c 0%c   
Tan, S. S., et al. (2016) 100%a 57%b 
Thomas, K. S., et al. (2005) 92%a   71%a 
Torkki, M., et al. (2002) 50%b 71%a   
Whitehurst, D. G. T., et al. (2011) 100%a   71%a 
Witt, C. M., et al. (2006) 31%c   57%b 
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Table 5: Matrix of reported clinical and cost effectiveness evidence 
   Declining effectiveness   
      
   1 
(evidence of greater effectiveness) 
2 
(evidence of no difference in effectiveness) 
3 



















































(21) water-based exercise vs usual care for 
hip OA and knee OA  
  
(24)  exercise-based rehabilitation program 
vs usual care for knee pain 
  
(38) Exercise and telephone support vs 
telephone support for knee pain 
  
(42)  mud-bath therapy added to standard 













































 (24) exercise-based rehabilitation program 
vs usual care for knee pain 
  
(20) pain coping skills training/exercise vs 
exercise for knee OA 
  
(20) pain coping skills training/exercise vs 
PCST for knee OA 
(22) behavioural graded activity vs usual 
care for hip OA and knee OA 
  
(17, 18) class-based exercise programme 
+ home exercise programme vs home 
exercise programme for knee OA 
  
(40) advice and exercise plus true 
acupuncture vs advice and exercise plus 



















































(32) manual therapy vs usual care for hip 
OA and knee OA 
  
(32) exercise therapy vs usual care for hip 
OA and knee OA 
  
(32) manual and exercise therapy vs usual 
care for hip OA and knee OA 
  
(43) Diet and exercise vs health lifestyle 
control  
  
(40) advice and exercise plus true 
acupuncture vs advice and exercise for 
knee OA 
(24) Group-based exercise-based 
rehabilitation program vs individual-
based exercise programme for knee pain 
  
(31) arthritis self-management 
programme plus an education booklet vs 
education booklet (reflects standard 
care) for hip OA and knee OA 
  
(62) Diet vs healthy lifestyle control for 
knee OA 
  
(62) exercise vs healthy lifestyle control 
for knee OA 
(20) pain coping 
skills training vs 











































   
Matrix adapted with permissions from hardcopy of Donaldson, C., M. Mugford, and L. Vale, Evidence-based Health Economics: 
From effectiveness to efficiency in systematic review. 1 ed. 2002: BMJ Books. 168 (8), now available as eBook from Wiley. Evidence 

















Figure 1: PRISMA diagram for Systematic review  
 













niversity user on 12 Septem
ber 2018
